These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 35674087)
1. Progress in the mechanism of neuronal surface P antigen modulating hippocampal function and implications for autoimmune brain disease. Barake F; Bravo-Zehnder M; González A Curr Opin Neurol; 2022 Jun; 35(3):436-442. PubMed ID: 35674087 [TBL] [Abstract][Full Text] [Related]
3. Pathogenicity of lupus anti-ribosomal P antibodies: role of cross-reacting neuronal surface P antigen in glutamatergic transmission and plasticity in a mouse model. Segovia-Miranda F; Serrano F; Dyrda A; Ampuero E; Retamal C; Bravo-Zehnder M; Parodi J; Zamorano P; Valenzuela D; Massardo L; van Zundert B; Inestrosa NC; González A Arthritis Rheumatol; 2015 Jun; 67(6):1598-610. PubMed ID: 25709106 [TBL] [Abstract][Full Text] [Related]
4. Antibodies and the brain: antiribosomal P protein antibody and the clinical effects in patients with systemic lupus erythematosus. González A; Massardo L Curr Opin Neurol; 2018 Jun; 31(3):300-305. PubMed ID: 29461425 [TBL] [Abstract][Full Text] [Related]
5. Anti-ribosomal P protein autoantibodies from patients with neuropsychiatric lupus impair memory in mice. Bravo-Zehnder M; Toledo EM; Segovia-Miranda F; Serrano FG; Benito MJ; Metz C; Retamal C; Álvarez A; Massardo L; Inestrosa NC; González A Arthritis Rheumatol; 2015 Jan; 67(1):204-14. PubMed ID: 25302407 [TBL] [Abstract][Full Text] [Related]
6. Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-D-Aspartate Receptor. Chang EH; Volpe BT; Mackay M; Aranow C; Watson P; Kowal C; Storbeck J; Mattis P; Berlin R; Chen H; Mader S; Huerta TS; Huerta PT; Diamond B EBioMedicine; 2015 Jul; 2(7):755-64. PubMed ID: 26286205 [TBL] [Abstract][Full Text] [Related]
7. Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus. Massardo L; Bravo-Zehnder M; Calderón J; Flores P; Padilla O; Aguirre JM; Scoriels L; González A Lupus; 2015 May; 24(6):558-68. PubMed ID: 25318968 [TBL] [Abstract][Full Text] [Related]
8. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Kowal C; Degiorgio LA; Lee JY; Edgar MA; Huerta PT; Volpe BT; Diamond B Proc Natl Acad Sci U S A; 2006 Dec; 103(52):19854-9. PubMed ID: 17170137 [TBL] [Abstract][Full Text] [Related]
9. Early Growth Response 1 (Egr-1) Regulates N-Methyl-d-aspartate Receptor (NMDAR)-dependent Transcription of PSD-95 and α-Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid Receptor (AMPAR) Trafficking in Hippocampal Primary Neurons. Qin X; Jiang Y; Tse YC; Wang Y; Wong TP; Paudel HK J Biol Chem; 2015 Dec; 290(49):29603-16. PubMed ID: 26475861 [TBL] [Abstract][Full Text] [Related]
10. Predictors of damage accrual in systemic lupus erythematosus: a longitudinal observational study with focus on neuropsychological factors and anti-neuronal antibodies. Mimica M; Barra I; Ormeño R; Flores P; Calderón J; Padilla O; Bravo-Zehnder M; González A; Massardo L Clin Rheumatol; 2019 Nov; 38(11):3129-3137. PubMed ID: 31367942 [TBL] [Abstract][Full Text] [Related]
11. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy. Levite M J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016 [TBL] [Abstract][Full Text] [Related]
12. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530 [TBL] [Abstract][Full Text] [Related]
13. Fatigue in SLE: diagnostic and pathogenic impact of anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies. Schwarting A; Möckel T; Lütgendorf F; Triantafyllias K; Grella S; Boedecker S; Weinmann A; Meineck M; Sommer C; Schermuly I; Fellgiebel A; Luessi F; Weinmann-Menke J Ann Rheum Dis; 2019 Sep; 78(9):1226-1234. PubMed ID: 31186256 [TBL] [Abstract][Full Text] [Related]
14. Association of hippocampal atrophy with cerebrospinal fluid antibodies against the NR2 subtype of the N-methyl-D-aspartate receptor in patients with systemic lupus erythematosus and patients with primary Sjögren's syndrome. Lauvsnes MB; Beyer MK; Kvaløy JT; Greve OJ; Appenzeller S; Kvivik I; Harboe E; Tjensvoll AB; Gøransson LG; Omdal R Arthritis Rheumatol; 2014 Dec; 66(12):3387-94. PubMed ID: 25156222 [TBL] [Abstract][Full Text] [Related]
15. Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis. Matus S; Burgos PV; Bravo-Zehnder M; Kraft R; Porras OH; Farías P; Barros LF; Torrealba F; Massardo L; Jacobelli S; González A J Exp Med; 2007 Dec; 204(13):3221-34. PubMed ID: 18056288 [TBL] [Abstract][Full Text] [Related]
16. Tripchlorolide improves age-associated cognitive deficits by reversing hippocampal synaptic plasticity impairment and NMDA receptor dysfunction in SAMP8 mice. Lin N; Pan XD; Chen AQ; Zhu YG; Wu M; Zhang J; Chen XC Behav Brain Res; 2014 Jan; 258():8-18. PubMed ID: 24140565 [TBL] [Abstract][Full Text] [Related]
17. Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. Faust TW; Chang EH; Kowal C; Berlin R; Gazaryan IG; Bertini E; Zhang J; Sanchez-Guerrero J; Fragoso-Loyo HE; Volpe BT; Diamond B; Huerta PT Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18569-74. PubMed ID: 20921396 [TBL] [Abstract][Full Text] [Related]